Cytek Biosciences (CTKB) Share-based Compensation (2020 - 2026)
Cytek Biosciences' (CTKB) quarterly Share-based Compensation came in at $5.5 million in Q4 2025, up 412.23% YoY from $1.1 million in Q4 2024, and down 1.97% on a QoQ basis from $5.6 million in Q3 2025.
Cytek Biosciences (CTKB) Share-based Compensation (2020 - 2026) Analysis & Trends
Cytek Biosciences (CTKB) has 6 years of Share-based Compensation data on file, last reported at $5.5 million in Q4 2025.
- Quarterly Share-based Compensation rose 412.23% year-over-year to $5.5 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $18.0 million (up 384.48% YoY) and the FY2025 annual result came in at $24.6 million, up 805.19% from the prior year.
- Share-based Compensation declined to $5.5 million in Q4 2025, from $5.6 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $22.0 million in Q4 2023 to a low of -$12.1 million in Q4 2022.
- A 5-year average of $2.8 million and a median of $3.9 million in 2022 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2021 — Share-based Compensation jumped 1009.96% — and 2022, when it tumbled 503.26%.
- Tracing CTKB's Share-based Compensation over 5 years: stood at $3.0 million in 2021, then plunged by 503.26% to -$12.1 million in 2022, then soared by 281.76% to $22.0 million in 2023, then sank by 95.11% to $1.1 million in 2024, then surged by 412.23% to $5.5 million in 2025.
- The last three Share-based Compensation figures came in at $5.5 million (Q4 2025), $5.6 million (Q3 2025), and $6.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Cytek Biosciences | 605.23 Mn | 531.38 Mn | 28.34 Mn | 5.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.34 Mn |
| Jun 30, 2026 | 5.34 Mn |
| Mar 31, 2026 | 4.86 Mn |
| Mar 31, 2026 | 4.86 Mn |
| Dec 31, 2025 | 5.53 Mn |
| Dec 31, 2025 | 5.53 Mn |
| Sep 30, 2025 | 5.64 Mn |
| Sep 30, 2025 | 5.64 Mn |
| Jun 30, 2025 | 6.79 Mn |
| Jun 30, 2025 | 6.79 Mn |
| Mar 31, 2025 | 6.63 Mn |
| Mar 31, 2025 | 6.63 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Jun 30, 2024 | -5.64 Mn |
| Jun 30, 2024 | -5.64 Mn |
| Mar 31, 2024 | 5.64 Mn |
| Mar 31, 2024 | 5.64 Mn |